Day 3 :
- Track 17: Obesity Treatment
Session Introduction
Rui Azevedo Guerreiro
Hospital EspÃrito Santo, Portugal
Title: Ophthalmic Complications of Bariatric Surgery
Biography:
Rui Azevedo Guerreiro has graduated in Medicine from NOVA Medical School in Lisbon, Portugal and is currently attending the Clinical Scholars Research Training Program from Harvard Medical School. Rui worked in the Bariatric and Metabolic Diseases Surgical Unit of the Central Lisbon Hospital Centre where, together with Rui Ribeiro, president of the Portuguese Society of Bariatric Surgery and Metabolic Diseases, developed his work on “Ophthalmic complications of Bariatric Surgeryâ€.
Abstract:
Obesity is increasing vastly in the world, and the number of bariatric surgeries being performed is also increasing. Patients being submitted to bariatric surgeries, especially malabsorptive procedures, have an increased risk of developing nutrient deficiencies, which can culminate in symptomatic hypovitaminosis, if supplementation is not done correctly. The eye and the optic system need an adequate level of several vitamins and minerals to perform properly, especially vitamin A, and my presentation wants to cover the main nutrients involved, the possible ophthalmic complications that can arise by their deficiency, and the management of those complications.
Jianfang Li
People’s Hospital of Xiaoshan, China
Title: Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis
Biography:
Jianfang Li has completed his MD at the age of 27 years from Wenzhou Medical University. He has published more than 6 papers in reputed journals and has been serving as an editorial board member of repute.
Abstract:
Abstract Our aim was to compare laparoscopic Roux-enY gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy(LSG) for treating morbid obesity and its related comorbidities. An electronic literature search was performed from inception to May 2015 and a total of 18,455 patients, enrolled in 62 recent studies, were included in this meta-analysis. Patients receiving LRYGB had a significantly higher percentage of excess weight loss and better resolution of hypertension, dyslipidemia, gastroesophageal reflux disease, and arthritis compared with those receiving LSG. LRYGB and LSG showed similar effects on type 2 diabetes mellitus and sleep apnea.
- Track 13: Obesity and Diabetes